Michigan Biomarker Alliance Joins C-Path Institute's Predictive Safety Testing Consortium | GenomeWeb
NEW YORK (GenomeWeb News) – ClinXus, a non-profit biomarker alliance based in Grand Rapids, Mich., has joined the Critical Path Institute’s Predictive Safety Testing Consortium, ClinXus said today.
 
ClinXus was formed in 2006 using $1.5 million from the Michigan 21st Century Jobs Fund and from in-kind donations from its members, which include the Van Andel Institute, Spectrum Health, Saint Mary’s Health Care, Jasper Clinical Research & Development, Grand Valley State University, and Grand Valley Medical Specialists.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.